Somaliland Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Somaliland Health Watch.

Press releases published on October 25, 2026

Oct. 25, 2026

Global fish oil supply under pressure as production heads towards decade low

Indeterminate EIN Presswire

Oct. 25, 2026

Miracle Surrogacy Welcomes More Than 30 Families to Private Consultations in Washington, D.C.

Indeterminate EIN Presswire

Oct. 25, 2026

Handicap Placard Qualifying Conditions: HandicapMD Launches Eligibility Resource Center

Indeterminate EIN Presswire

Oct. 25, 2026

Miracle Surrogacy Holds Quarterly Journey Coordination Meetings in Mexico City and Cancun

Indeterminate EIN Presswire

Oct. 25, 2026

Research Raises Medication Diversion Concerns in U.S. Jails and Prisons as SPECTROM Introduces Real-Time Accountability

Indeterminate EIN Presswire

Oct. 25, 2026

EverNear Develops AI Voice Companion to Support Older Adults Living With Alzheimer's Disease

Indeterminate EIN Presswire

Oct. 25, 2026

Medicare Agents Helpline Guides Seniors on Applying for Medicare and Comparing Plan Quality

Indeterminate EIN Presswire

Oct. 25, 2026

VANDERBILT UNIVERSITY'S AUDREY SWANK AND BETHEL UNIVERSITY'S HUDSON WALLACE WIN NASHVILLE HALF MARATHON

Indeterminate EIN Presswire

Oct. 25, 2026

Ohio Disability Parking Permits: HandicapMD Explains Online Medical Certification and Eligibility

Indeterminate EIN Presswire

Oct. 25, 2026

KFSH Expands Virtual Care Pathways to Bring Specialized Follow-Up Closer to Patients

Indeterminate EIN Presswire

Oct. 25, 2026

Leads Biolabs' LBL-034 Shows 21.8-Month Median PFS in First-in-Human RRMM Data at ESMO 2026, Validating Its Proprietary TCE Platform

Indeterminate GlobeNewswire

Oct. 25, 2026

ArriVent Announces Initial Phase 1 Data for CDH17-targeted ADC ARR-217 in Patients with Gastrointestinal Cancers at ESMO Congress 2026

Indeterminate GlobeNewswire

Oct. 25, 2026

Amarin Provides Update on University of Leeds Sponsored Phase 3 EPA for Metastasis Trial 2 (EMT2) Evaluating VAZKEPA®/VASCEPA® (icosapent ethyl) Capsules on Top of Standard of Care Treatment in Patients Undergoing Liver Resection for Colorectal Cancer …

Indeterminate GlobeNewswire

Oct. 25, 2026

Libtayo® (cemiplimab) Longer-Term Data Show Increasing and Clinically Meaningful Overall Survival Benefit with Adjuvant Treatment in High-Risk Cutaneous Squamous Cell Carcinoma (CSCC)

Indeterminate GlobeNewswire

Oct. 25, 2026

KFSH Expands Virtual Care Pathways to Bring Specialized Follow-Up Closer to Patients

Indeterminate GlobeNewswire